PureTech Share Price (PRTC)

On a lighter note if there is one! What is that board room photo about? It looks like a teachers staff room with a car rental firm outside. Cans of coke and old Sandy slumped in the corner with principal Zohar still in attendance.Alan Sugar would be raging.They are a leading Bio company supposedly.Moan over.

Thanks for your contribution, JSB1989. You may well be right but even if you are,it does not entirely preclude my comment.

I probably will hold on to my entire holding, which is only about 3% of the whole portfolio. There is a reasonable chance of a U.S bid if the SP stays so undervalued and that would have to be at a much higher price. You have different considerations since it is presumably a much higher % of your portfolio. All the best!

Interesting theories about the tender offer. I’m undecided on what to do on whether to allocate some shares or not and the %. It’s my biggest holding by a mile. 250p is very undervalued but it’s debating whether the market will clock onto the value.

Oldbutnowisa - I can’t see them taking many or any of the entities the full way to commercialisation alone. I’ve been reading the annual report and they have mentioned partnership scenarios if LYT-100 is successful in Q4 and moves forwards to Phase 3. Gallop will shortly follow in the footsteps of Seaport with a financing round. That won’t leave any wholly owned entities which I’m happy with as I like the model from a risk / reward perspective. Unfortunately it’s not one which the market appreciates.

One thing holding the sp back is the lack of clarity on NAV as none of the significant founded entities are listed. If Vedanta or Seaport were to list, we’d have a reference point for a valuation.

I have seen 'pundits' moaning that they make no annual profits, which is bound to discourage investors. Their model is responsible for this. They will only build up profits after the products of their inventions are in production and the terms of those contracts take effect. Under their contract terms of sale, the purchasers pay royalties to Purehealth and milestone payments. This will obviously take some years and until then, once their companies set up to invent hopefully are sold for big cash this will accrue to Purehealth but as capital. If, like me, you believe in that model, why worry about temporary lack of annual profits?

As I inferred below, I'm really afraid that their strategy is to make 250 look really attractive by somehow keeping the SP down until the close of tender, then suddenly allocating another 10-20million to it and wiping out the RI base in one swoop. I also think all the major IIs are unofficially in on it and won't tender.

Please, someone who isn't such a conspiracy theorist as me explain to me why this won't / can't happen.

I would genuinelly like to tender 20% and get 20%. I don't want to have to tender 100% in the hope of getting 20% and then lose the lot for a paltry 250.